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challenges in renal research. Previous 
research has identified the involvement 
of many cytokines in its genesis. Using 
whole-genome scanning, recent studies 
identified an association between the inter-
leukin-6 (IL-6) haplotype and decreased 
GFR in type 2 diabetes. Since IL-6 signals 
through the Janus kinase/signal transducer 
and activator of transcription pathway, Lu 
et al. studied the role of Stat3 in the devel-
opment of diabetic nephropathy in mice 
with reduced function of this transcription 
factor. The number of glomeruli in these 
mice was the same as in wild-type mice, 
indicating that low Stat3 activity does not 
prevent branching morphogenesis and 
kidney development. When diabetes was 
induced in these mice, they also developed 
hyperfiltration, a salient feature of diabetic 
nephropathy long thought to be necessary 
for development of disease. Despite this 
development, expression of the markers of 
inflammation and fibrosis in the diabetic 
kidneys of mice with low levels of Stat3 
was significantly reduced. These studies 
demonstrate that the pathway of Stat3 
Metabolic anomalies 
in mild CKD
Advanced chronic kidney disease (CKD) is 
associated with several metabolic anoma-
lies, such as high phosphorus, uric acid, 
homocysteine, fibrinogen, and C-reactive 
protein, as well as anemia. While the ori-
gins of these anomalies are not known, 
they are assoc iated with poor prognoses. 
But when do these anomalies develop—
early in the course of CKD, or much later? 
To address this question, Muntner et al. 
examined both estimated glomerular filtra-
tion rate (eGFR), using the Modification of 
Diet in Renal Disease (MDRD) formula, 
and cystatin C elevation in participants 
included in the Third National Health and 
Nutrition Examination Survey database. As 
expected, metabolic anomalies were com-
mon in advanced CKD patients. Metabolic 
anomalies were also found in the patients 
with normal or mildly reduced eGFR 
who had elevated levels of cystatin C. The 
interpretation of these results leaves room 
for discussion. Is cystatin C a metabolic 
anomaly itself, or does eGFR using the 
MDRD equation fail to identify patients 
with reduced GFR? See page 81.
Stat3 in diabetic 
nephropathy: from 
bedside to bench
The mechanism by which diabetes induces 
nephropathy remains one of the greatest 
activation may be pathogenic in diabetic 
nephropathy. See page 63.
Outcomes of 
automated and 
continuous ambulatory 
peritoneal dialysis  
are equivalent 
Which mode of dialysis—hemodialysis 
or peritoneal—is better? The ‘classic’ 
answer has been that the latter is bet-
ter. A long list of potential explana-
tions exists, including middle molecule 
clearance, and the fact that peritoneal 
dialysis is well tolerated, convenient, 
and more affordable. The recent tech-
nological development of automated 
cycling machines suggests a perceived 
advantage over continuous ambulatory 
peritoneal dialysis. In a study reported 
in this issue, Mehrotra et al. sought to 
determine whether recent improvements 
in the outcomes of patients with chronic 
peritoneal dialysis could be due to the 
use of automated cycling machines. The 
authors analyzed the United States Renal 
Data System database for the outcomes of 
these two methods of administering peri-
toneal dialysis. The authors found little 
or no difference in the risk of death or in 
technique failure between the modalities 
of treatment. Thus, improved outcomes 
of chronic peritoneal dialysis cannot be 
attributed to a greater use of automated 
cycling machines. See page 97.
It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
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